SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001546927-15-000122
Filing Date
2015-04-20
Accepted
2015-04-20 16:37:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 camberprotalixform13v1.htm SC 13G 40705
2 JOINT FILING AGREEMENT camberprotalix13gaex1v1.htm EX-1 2582
  Complete submission text file 0001546927-15-000122.txt   45034
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 15781021
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G